Category: Guest content

Has Bio-Pharma Forgotten to Fail Early?

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below.  When I started working for PhRMA nearly 15 years ago, the mantra was “Fail early, Fail cheap.” Given the exponentially increased cost of advancing compounds pre-clinical into clinical research […]


Is the Clinical Research Enterprise in Decline?

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. It looks like the ‘new normal’ is not just for biotechnology startups and SME pharma companies  – the CROs (and other vendors) who previously benefited from better R&D funding streams also […]


The FDA’s modernisation of its bioprocess regulation

This is a guest post from the BiotechBlog Intern,  Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin City University. Do you have a response to Fintan’s post? Respond in the comments section below. It has now been more than a year since the FDA published a welcomed revision of the 1987 […]


Mark Levin, Third Rock Ventures: Personalized Medicine Needs Teamwork and Collaboration

Mark Levin, Third Rock Ventures: Personalized Medicine Needs Teamwork and Collaboration

For Third Rock Ventures' Mark Levin, personalized medicine is nothing new. Instead, he sees the history of pharma as a gradual homing in on the roots of dise…


3D Cell Cultures

This is a guest post from the BiotechBlog Intern,  Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin City University. Do you have a response to Fintan’s post? Respond in the comments section below. As researchers continue to investigate the complex nature of cell tissues and their behaviour, it is becoming […]


Can Waste Gasification Quell A Future Energy Crisis?

This is a guest post from the BiotechBlog Intern,  Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin City University. Do you have a response to Fintan’s post? Respond in the comments section below. One of the most overlooked but consistent problems facing many governments is waste management. Despite healthy recycling […]


The Role of Cell Line Authentication in Today’s Biotechnology World

This is a guest post from Erin M. Hall. Erin is the Technical Leader at Genetica DNA Laboratories, Inc. located in Cincinnati, OH. Do you have a response to Erin’s post? Respond in the comments section below. It is estimated that 18-36% of all actively growing cell line cultures are misidentified and/or cross-contaminated with another […]


Guest Post: Biotechnology Patent Trolls

This is a guest post from the BiotechBlog Intern,  Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin City University. Do you have a response to Fintan’s post? Respond in the comments section below. According to a BDO industry report, a smallUS biotech company in 2010 enjoyed average revenues of around […]